Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP vs CyA in Severe HSP Nephritis
NCT00425724Phase 4Completed
- Sponsor
- Oulu University Hospital
- Start
- Jan 2000
- Primary completion
- Feb 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine in IgA vasculitis nephritis (2 arms), sponsored by Oulu University Hospital. Primary endpoints: Disappearance of proteinuria/hematuria at 24 months, Renal function (GFR) at 24 months and 1 more. Started Jan 2000; status: completed.
02
Drugs
cyclosporine
03
Conditions
IgA vasculitis nephritis
Beyond the preview
Go deeper on NCT00425724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425724.